Jin Dazhi, Luo Yun, Huang Chen, Cai Jian, Ye Julian, Zheng Yi, Wang Liqian, Zhao Peng, Liu Anbing, Fang Weijia, Wang Xianjun, Xia Shichang, Jiang Jianmin, Tang Yi-Wei
Department of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, China
Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
J Clin Microbiol. 2017 Mar;55(3):801-810. doi: 10.1128/JCM.01898-16. Epub 2016 Dec 14.
Few studies on risk factors for and transmission of infection (CDI) in China have been reported. A cross-sectional study was conducted for 3 years in eastern China. Consecutive stool specimens from hospitalized patients with diarrhea were cultured for isolates from these patients then were analyzed for toxin genes, genotypes, and antimicrobial resistance. A severity score for the CDI in each patient was determined by a blinded review of the medical record, and these scores ranged from 1 to 6. A total of 397 out of 3,953 patients (10.0%) with diarrhea were found to have CDI. Severity of CDI was mild to moderate, and the average (± standard deviation) severity score was 2.61 ± 1.01. was isolated from stool specimens in 432 (10.9%) of all the patients who had diarrhea. genotypes were determined by multilocus sequence analysis and PCR ribotyping; sequence type 37 (ST37)/ribotype 017 (RT017) ( = 68, 16.5%) was the dominant genotype. Eleven patients (16.2%) with this genotype had a CDI severity score of 5. Overall, three RTs and four STs were predominant; these genotypes were associated with significantly different antimicrobial resistance patterns in comparison to all genotypes (χ = 79.56 to 97.76; < 0.001). Independent risk factors associated with CDI included age greater than 55 years (odds ratio [95% confidence interval], 26.80 [18.76 to 38.29]), previous hospitalization (12.42 [8.85 to 17.43]), previous antimicrobial treatment within 8 weeks (150.56 [73.11 to 310.06]), hospital stay more than 3 days before sampling (2.34 [1.71 to 3.22]), undergoing chemotherapy (3.31 [2.22 to 4.92]), and undergoing abdominal surgery (4.82 [3.54 to 6.55]). CDI is clearly a problem in eastern China and has a prevalence of 10.0% in hospitalized patients. Among risk factors for CDI, the advanced age threshold was younger for Chinese patients than that reported for patients in developed countries.
中国关于艰难梭菌感染(CDI)的危险因素及传播的研究报道较少。在中国东部进行了一项为期3年的横断面研究。对腹泻住院患者的连续粪便标本进行培养,分离出这些患者的菌株,然后分析毒素基因、基因型和抗菌药物耐药性。通过对病历的盲法审查确定每位患者CDI的严重程度评分,这些评分范围为1至6分。3953例腹泻患者中共有397例(10.0%)被发现患有CDI。CDI的严重程度为轻度至中度,平均(±标准差)严重程度评分为2.61±1.01。在所有腹泻患者中有432例(10.9%)的粪便标本中分离出了[未明确的某种菌]。通过多位点序列分析和PCR核糖体分型确定[未明确的某种菌]的基因型;序列类型37(ST37)/核糖体分型017(RT017)(n = 68,16.5%)是主要基因型。11例(16.2%)具有该基因型的患者CDI严重程度评分为5分。总体而言,三种核糖体分型和四种序列类型占主导;与所有基因型相比,这些基因型具有显著不同的抗菌药物耐药模式(χ² = 79.56至97.76;P < 0.001)。与CDI相关的独立危险因素包括年龄大于55岁(优势比[95%置信区间],26.80[18.76至38.29])、既往住院史(12.42[8.85至17.43])、8周内既往抗菌药物治疗史(150.56[73.11至310.06])、采样前住院时间超过3天(2.34[1.71至3.22])、接受化疗(3.31[2.22至4.92])以及接受腹部手术(4.82[3.54至6.55])。CDI在中国东部显然是一个问题,在住院患者中的患病率为10.0%。在CDI的危险因素中,中国患者的高龄阈值比发达国家报道的患者要低。